Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Åberg

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
BMC Neurology|August 8, 2018
Altered levels of circulating insulin-like growth factor I (IGF-I) following ischemic stroke are associated with outcome - a prospective observational studyN David Åberg, Daniel Åberg, Katarina Jood, et al.
International Journal of Molecular Sciences|May 11, 2024
A Nonlinear Relation between Body Mass Index and Long-Term Poststroke Functional Outcome-The Importance of Insulin Resistance, Inflammation, and Insulin-like Growth Factor-Binding Protein-1Gustaf Gadd, Daniel Åberg, Alexander Wall, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Increased Cerebrospinal Fluid Level of Insulin-like Growth Factor-II in Male Patients with Alzheimer's DiseaseDaniel Åberg, Per Johansson, Jörgen Isgaard, et al.
International Journal of Molecular Sciences|June 10, 2023
Serum IGFBP-1 Concentration as a Predictor of Outcome after Ischemic Stroke-A Prospective Observational StudyDaniel Åberg, Gustaf Gadd, Katarina Jood, et al.
Biomedicines|March 8, 2020
Relationship between Levels of Pre-Stroke Physical Activity and Post-Stroke Serum Insulin-Like Growth Factor IN David Åberg, Gustaf Gadd, Daniel Åberg, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|July 2, 2019
Association Between Levels of Serum Insulin-like Growth Factor I and Functional Recovery, Mortality, and Recurrent Stroke at a 7-year Follow-upN David Åberg, Daniel Åberg, Cecilia Lagging, et al.
Psychoneuroendocrinology|March 12, 2013
Serum but not cerebrospinal fluid levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are increased in Alzheimer's diseasePer Johansson, Daniel Åberg, Jan-Ove Johansson, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
BMC Neurology|August 8, 2018
Altered levels of circulating insulin-like growth factor I (IGF-I) following ischemic stroke are associated with outcome - a prospective observational studyN David Åberg, Daniel Åberg, Katarina Jood, et al.
International Journal of Molecular Sciences|May 11, 2024
A Nonlinear Relation between Body Mass Index and Long-Term Poststroke Functional Outcome-The Importance of Insulin Resistance, Inflammation, and Insulin-like Growth Factor-Binding Protein-1Gustaf Gadd, Daniel Åberg, Alexander Wall, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Increased Cerebrospinal Fluid Level of Insulin-like Growth Factor-II in Male Patients with Alzheimer's DiseaseDaniel Åberg, Per Johansson, Jörgen Isgaard, et al.
International Journal of Molecular Sciences|June 10, 2023
Serum IGFBP-1 Concentration as a Predictor of Outcome after Ischemic Stroke-A Prospective Observational StudyDaniel Åberg, Gustaf Gadd, Katarina Jood, et al.
Biomedicines|March 8, 2020
Relationship between Levels of Pre-Stroke Physical Activity and Post-Stroke Serum Insulin-Like Growth Factor IN David Åberg, Gustaf Gadd, Daniel Åberg, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|July 2, 2019
Association Between Levels of Serum Insulin-like Growth Factor I and Functional Recovery, Mortality, and Recurrent Stroke at a 7-year Follow-upN David Åberg, Daniel Åberg, Cecilia Lagging, et al.
Psychoneuroendocrinology|March 12, 2013
Serum but not cerebrospinal fluid levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are increased in Alzheimer's diseasePer Johansson, Daniel Åberg, Jan-Ove Johansson, et al.
Pageof 2